09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

indicate that the most sensitive site(s) are not relevant to human cancer induction, or represent data sets<br />

with unusually wide error bounds. As an alternative, where several equally plausible results are available<br />

and are sufficiently close to be regarded as concordant, the geometric mean of all such estimates may be<br />

used.<br />

Pharmacokinetic modeling, which would allow the comparison of different routes and correct for<br />

nonlinearities in the relationship between applied and internal dose, was not available for the mouse.<br />

Therefore, the potency estimates obtained in the rat were preferred for risk assessment purposes.<br />

Because the results in rats and mice are comparable, the use of the rat data was consistent with the<br />

policy of selecting appropriately sensitive species as the basis for the estimate of potency in humans.<br />

Table 4:<br />

Dose Response Parameters for MTBE Carcinogenicity Studies<br />

a) Inhalation studies - ppm in air as dose metric<br />

Species Sex Tumor site and type LED 10<br />

(ppm)<br />

CSF<br />

(ppm -1 )<br />

mouse a female hepatocellular adenoma + carcinoma 320 3.2 × 10 -4<br />

male hepatocellular adenoma + carcinoma 140 7.0 × 10 -4<br />

rat b male renal tubular cell adenoma + carcinoma 240 4.2 × 10 -4<br />

testicular interstitial cell tumors 46 2.2 × 10 -3<br />

a Burleigh-Flayer et al. 1992, Bird et al. 1997<br />

b<br />

Chun et al., 1992; Bird et al., 1997.<br />

Assumed: Data reassessment by U.S. EPA (1994c, 1995c).<br />

Duration correction based on (t e /t l ) 3 : t l = 104 weeks for both rats and mice.<br />

Interspecies correction: ppm equivalency.<br />

b) Rat oral and inhalation studies - Equivalent oral dose as dose metric<br />

Route Sex Tumor site and type LED 10<br />

(mg/kg-day)<br />

CSF<br />

(mg/kg/day) -1<br />

Inhalation a Male Male renal tubular cell adenoma + carcinoma 55 1.8 × 10 -3<br />

Testicular interstitial cell tumors 11 8.7 × 10 -3<br />

Gavage b Male Leydig cell tumors<br />

Original 1995 report 76 1.38 × 10 -3<br />

Revised 1998 data 64 1.55 × 10 -3<br />

Female Leukemia/lymphoma<br />

Original 1995 report 49 2.03 × 10 -3<br />

Revised 1998 data 48 2.09 × 10 -3<br />

a<br />

Chun et al., 1992.<br />

b Belpoggi et al., 1995, 1998.<br />

Assumed: Data reassessment by U.S. EPA (1994c, 1995c) for Chun et al. (1992) study.<br />

353

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!